scholarly article | Q13442814 |
P356 | DOI | 10.1200/JCO.1999.17.7.2256 |
P698 | PubMed publication ID | 10561283 |
P2093 | author name string | A S Coates | |
P N Butow | |||
S M Dunn | |||
P433 | issue | 7 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | metastatic melanoma | Q18975855 |
P304 | page(s) | 2256-2263 | |
P577 | publication date | 1999-07-01 | |
P1433 | published in | Journal of Clinical Oncology | Q400292 |
P1476 | title | Psychosocial predictors of survival in metastatic melanoma. | |
P478 | volume | 17 |
Q34371938 | Assessment of patient-reported outcomes in patients with melanoma |
Q34021000 | Associations of social networks with cancer mortality: a meta-analysis. |
Q35551141 | Baseline psychosocial predictors of survival in localised breast cancer |
Q38802820 | Beliefs and practices of patients with advanced cancer: implications for communication |
Q47295869 | COMSKIL Communication Training in Oncology-Adaptation to German Cancer Care Settings |
Q47637288 | Cancer-specific social support received by newly diagnosed cancer patients: validating the new Structural-Functional Social Support Scale (SFSS) measurement tool |
Q35925238 | Communication skills training for oncology professionals |
Q40315498 | Comparison of quality of life among long-term melanoma survivors and non-melanoma controls: a cross-sectional study. |
Q58311627 | Considerations of psychosocial illness phase in cancer survival |
Q35126567 | Coping with melanoma--ten strategies that promote psychological adjustment |
Q52165740 | Coping with metastatic melanoma: the last year of life. |
Q43906595 | Coping with prostate cancer: a quantitative analysis using a new instrument, the centre for clinical excellence in urological research coping with cancer instrument |
Q35634135 | Depression in cancer patients: a critical review |
Q55083087 | Determinants of illness-specific social support and its relation to distress in long-term melanoma survivors. |
Q64954576 | Early quality-of-life and psychological predictors of disease-free time and survival in localized prostate cancer. |
Q36703255 | Endosonographers' approach to delivering a diagnosis of pancreatic cancer: obligated but undertrained |
Q35466390 | Estimating the change in life expectancy after a diagnosis of cancer among the Australian population. |
Q40998898 | Helplessness/hopelessness, minimization and optimism predict survival in women with invasive ovarian cancer: a role for targeted support during initial treatment decision-making? |
Q47566992 | Hope, optimism and survival in a randomised trial of chemotherapy for metastatic colorectal cancer |
Q37054958 | Immunotherapy in the management of melanoma: current status |
Q33962394 | Influence of psychological coping on survival and recurrence in people with cancer: systematic review |
Q51020292 | Lack of marital support and poor psychological responses in male cancer patients. |
Q33354210 | Melanoma survivorship: research opportunities |
Q47821844 | Optimistic expectations and survival after hematopoietic stem cell transplantation |
Q53513183 | Patterns over time in quality of life, coping and psychological adjustment in late stage melanoma patients: an application of multilevel models. |
Q47344748 | Performance status 1 predicts psychological response in female, but not male, ambulatory cancer patients |
Q58545234 | Physician Empathy Interacts with Breaking Bad News in Predicting Lung Cancer and Pleural Mesothelioma Patient Survival: Timing May Be Crucial |
Q38673841 | Potential prognostic value of clinical characteristics, hormone status and major depressive disorder in breast cancer |
Q40414575 | Predictors of participation in clinical and psychosocial follow-up of the kConFab breast cancer family cohort |
Q44490957 | Prognostic value of quality of life scores for time to progression (TTP) and overall survival time (OS) in advanced breast cancer |
Q50797247 | Prospective assessment of the reliability, validity, and sensitivity to change of the Functional Assessment of Cancer Therapy-Melanoma questionnaire. |
Q36621564 | Psychosocial predictors of outcome: time to relapse and survival in patients with early stage melanoma |
Q40308580 | Quality of life as a potential predictor for morbidity and mortality in patients with metastatic hormone-refractory prostate cancer |
Q22241762 | Quality of life data as prognostic indicators of survival in cancer patients: an overview of the literature from 1982 to 2008. |
Q44509490 | Quality of life evaluation in a randomised trial of chemotherapy versus bio-chemotherapy in advanced melanoma patients |
Q48285831 | Quality-of-life outcomes in patients with advanced melanoma: A review of the literature |
Q36149108 | Repression: finding our way in the maze of concepts |
Q34988141 | Research design in end-of-life research: state of science |
Q43577790 | Role functioning before start of adjuvant treatment was an independent prognostic factor for survival and time to failure. A report from the Nordic adjuvant interferon trial for patients with high-risk melanoma |
Q21144627 | Social relationships and mortality risk: a meta-analytic review |
Q52006060 | Social support and survival in patients with acute myeloid leukaemia. |
Q36891121 | The PROMIS initiative: involvement of rehabilitation stakeholders in development and examples of applications in rehabilitation research |
Q90020797 | The association between partner bereavement and melanoma: cohort studies in the U.K. and Denmark |
Q36393259 | The effect of psychosocial factors on breast cancer outcome: a systematic review |
Q44421258 | The health-related quality-of-life impact of histamine dihydrochloride plus interleukin-2 compared with interleukin-2 alone in patients with metastatic melanoma. |
Q38644501 | The role of stress and beta-adrenergic system in melanoma: current knowledge and possible therapeutic options |
Q49216159 | When do patient reported quality of life indicators become prognostic in breast cancer? |
Q84454010 | [Psycho-oncological aspects of malignant melanoma. A systematic review from 1990-2008] |
Search more.